7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 
      
    		                   
      assets
    		                   
      current assets:
    		                   
      cash and cash equivalents
    		140,664,000 127,337,000 122,675,000 192,434,000 192,638,000 280,663,000 342,615,000 360,382,000 370,541,000 377,602,000 236,422,000 194,611,000 101,737,000 108,659,000 119,064,000 136,627,000 150,069,000 167,477,000 184,986,000 
      marketable securities
    		475,256,000 522,636,000 571,987,000 297,447,000 294,725,000 220,282,000              
      prepaid expenses and other current assets
    		11,248,000 11,619,000 10,938,000 3,734,000 5,789,000 7,296,000 9,333,000 5,280,000 3,722,000 4,131,000 5,716,000 3,880,000 2,927,000 4,470,000 4,681,000 3,250,000 4,731,000 3,834,000 3,619,000 
      total current assets
    		627,168,000 661,592,000 705,600,000 493,615,000 493,152,000 508,241,000 351,948,000 365,662,000 374,263,000 381,733,000 242,138,000 198,491,000 104,664,000 113,129,000 124,068,000 140,100,000 154,800,000 171,311,000 188,605,000 
      property and equipment
    		1,228,000 1,289,000 1,370,000 751,000 79,000 98,000 211,000 170,000 183,000 159,000 180,000 168,000     180,000 229,000 229,000 
      right-of-use assets, operating leases
    		1,220,000 1,340,000 1,457,000 1,569,000 1,678,000 1,642,000 1,788,000 1,930,000 1,935,000 2,166,000 1,346,000 1,430,000        
      other assets
    		840,000 840,000 839,000 838,000 236,000 236,000 235,000 234,000 116,000 116,000 116,000 116,000 1,367,000 204,000 217,000 237,000 232,000 559,000 225,000 
      total assets
    		630,456,000 665,061,000 709,266,000 496,773,000 495,145,000 510,217,000 354,182,000 367,996,000 376,497,000 384,174,000 243,780,000 200,205,000 106,031,000 113,333,000 124,285,000 140,437,000 155,535,000 172,422,000 189,382,000 
      liabilities and stockholders’ equity
    		                   
      current liabilities:
    		                   
      accounts payable
    		7,268,000 6,350,000 6,703,000 7,948,000 3,553,000 4,749,000 5,269,000 12,629,000 8,496,000 5,214,000 5,642,000 16,162,000 1,139,000 1,618,000 5,110,000 2,950,000 939,000 1,492,000 3,562,000 
      accrued external research and development expenses
    		7,705,000 7,463,000 7,421,000 7,141,000 16,332,000 10,351,000              
      other accrued expenses
    		11,115,000 6,161,000 4,138,000 8,097,000 5,512,000 4,451,000              
      operating lease liabilities, current
    		656,000 632,000 479,000 130,000 76,000 759,000 767,000 665,000 353,000 321,000 313,000 307,000        
      total current liabilities
    		26,744,000 20,606,000 18,741,000 23,316,000 25,473,000 20,310,000 14,852,000 21,439,000 14,416,000 9,683,000 9,980,000 22,578,000 1,464,000 6,436,000 12,674,000 14,834,000 12,661,000 11,505,000 13,776,000 
      long-term debt
    		28,948,000 28,737,000 28,529,000 28,322,000                
      operating lease liabilities, non-current
    		1,373,000 1,553,000 1,634,000 1,548,000 1,712,000 1,078,000 1,259,000 1,436,000 1,607,000 1,772,000 945,000 1,027,000        
      total liabilities
    		57,065,000 50,896,000 48,904,000 53,186,000 27,185,000 21,388,000 16,111,000 22,875,000 17,523,000 12,955,000 10,925,000 23,605,000 1,464,000 6,436,000 12,674,000 15,596,000 14,674,000 14,740,000 18,221,000 
      commitments and contingencies
    		                   
      stockholders’ equity:
    		                   
      preferred stock, 0.0001 par value; 10,000,000 shares authorized, no shares issued or outstanding as of september 30, 2025 and december 31, 2024
    		                   
      common stock
    		4,000 3,000 3,000 3,000 3,000 3,000 2,000 2,000 2,000 2,000 2,000 2,000 4,000 4,000 4,000 4,000 4,000 4,000 4,000 
      additional paid-in capital
    		1,022,324,000 1,001,223,000 991,911,000 741,297,000 735,761,000 730,832,000 553,663,000 533,764,000 524,038,000 522,161,000 367,850,000 288,814,000 314,851,000 313,904,000 311,528,000 309,527,000 307,724,000 305,994,000 303,026,000 
      accumulated other comprehensive income
    		718,000 273,000 535,000 289,000 741,000               
      accumulated deficit
    		-449,655,000 -387,334,000 -332,087,000 -298,002,000 -268,545,000 -241,946,000 -215,594,000 -188,645,000 -165,066,000 -150,944,000 -134,997,000 -112,216,000 -210,288,000 -207,011,000 -199,921,000 -184,690,000 -166,867,000 -148,316,000 -131,869,000 
      total stockholders’ equity
    		573,391,000 614,165,000 660,362,000 443,587,000 467,960,000 488,829,000 338,071,000 345,121,000 358,974,000 371,219,000 232,855,000 176,600,000    124,841,000    
      total liabilities and stockholders’ equity
    		630,456,000 665,061,000 709,266,000 496,773,000 495,145,000 510,217,000 354,182,000 367,996,000 376,497,000 384,174,000 243,780,000     140,437,000    
      preferred stock, 0.0001 par value; 10,000,000 shares authorized, no shares issued or outstanding as of june 30, 2025 and december 31, 2024
    		                   
      preferred stock, 0.0001 par value; 10,000,000 shares authorized, no shares issued or outstanding as of march 31, 2025 and december 31, 2024
    		                   
      preferred stock, 0.0001 par value; 10,000,000 shares authorized, no shares issued or outstanding as of december 31, 2024 and december 31, 2023
    		                   
      accumulated other comprehensive loss
    		     -60,000              
      accrued expenses
    		      8,816,000 8,145,000 5,567,000 4,148,000 4,025,000 6,109,000        
      contingent value right liability
    		        1,500,000 1,500,000          
      liabilities, convertible preferred stock and stockholders’ equity
    		                   
      derivative liability
    		                   
      series seed convertible preferred stock, 0.0001 par value; no shares and 5,000,000 shares authorized at december 31, 2022 and 2021, respectively; no shares and 5,000,000 shares issued and outstanding as of december 31, 2022 and 2021, respectively;
    		                   
      series a convertible preferred stock, 0.0001 par value; no shares and 41,666,666 shares authorized as of december 31, 2022 and 2021, respectively; no shares and 41,666,666 shares issued and outstanding as of december 31, 2022 and 2021, respectively;
    		                   
      series b convertible preferred stock, 0.0001 par value; no shares and 37,499,999 shares authorized as of december 31, 2022 and 2021, respectively; no shares and 37,499,999 shares issued and outstanding as of december 31, 2022 and 2021, respectively;
    		                   
      stockholders’ equity
    		                   
      total liabilities, convertible preferred stock and stockholders’ equity
    		           200,205,000        
      restricted cash, current
    		              323,000 223,000    
      restricted cash, non-current
    		               100,000    
      liabilities and stockholders' equity
    		                   
      accrued expenses and other current liabilities
    		            325,000 1,905,000 3,405,000 6,884,000 6,722,000 5,013,000 5,214,000 
      term loan, current portion
    		             2,913,000 4,159,000 5,000,000 5,000,000 5,000,000 5,000,000 
      other liabilities
    		               358,000 366,000 346,000 316,000 
      term loan, net of current portion and discount
    		               404,000 1,647,000 2,889,000 4,129,000 
      stockholders' equity:
    		                   
      preferred stock, 0.0001 par value; 10,000,000 shares authorized; no shares issued and outstanding as of september 30, 2022 and december 31, 2021
    		                   
      total stockholders' equity
    		            104,567,000 106,897,000 111,611,000  140,861,000 157,682,000 171,161,000 
      total liabilities and stockholders' equity
    		            106,031,000 113,333,000 124,285,000  155,535,000 172,422,000 189,382,000 
      preferred stock, 0.0001 par value; 10,000,000 shares authorized; no shares issued and outstanding as of june 30, 2022 and december 31, 2021
    		                   
      preferred stock, 0.0001 par value; 10,000,000 shares authorized; no shares issued and outstanding as of march 31, 2022 and december 31, 2021
    		                   
      deferred offering costs
    		                   
      convertible notes
    		                   
      warrant liability
    		                   
      stockholders' equity
    		                   
      preferred stock, 0.0001 par value; 10,000,000 shares authorized; no shares issued and outstanding as of december 31, 2021 and 2020
    		                   
      restricted cash
    		                323,000 323,000 323,000 
      preferred stock, 0.0001 par value; 10,000,000 shares authorized; no shares issued and outstanding as of september 30, 2021 and december 31, 2020
    		                   
      preferred stock, 0.0001 par value; 10,000,000 shares authorized; no shares issued and outstanding as of june 30, 2021 and december 31, 2020
    		                   
      preferred stock, 0.0001 par value; 10,000,000 shares authorized; no shares issued and outstanding as of march 31, 2021 and december 31, 2020
    		                   
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.